UA43337C2 - Гормональний засіб для лікування вугрів - Google Patents
Гормональний засіб для лікування вугрівInfo
- Publication number
- UA43337C2 UA43337C2 UA95125308A UA95125308A UA43337C2 UA 43337 C2 UA43337 C2 UA 43337C2 UA 95125308 A UA95125308 A UA 95125308A UA 95125308 A UA95125308 A UA 95125308A UA 43337 C2 UA43337 C2 UA 43337C2
- Authority
- UA
- Ukraine
- Prior art keywords
- hormonal
- blackheads
- treating
- daily doses
- hormonal means
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Гормональний засіб для лікування вугрів включає два гормональні компоненти. При використанні цього засобу загальна кількість добових доз дорівнює загальній кількості діб у бажаному циклі. Перший гормональний компонент взято у кількості від 5 до 14, а другий - від 23 до 14 добових доз. Кількість добових доз першого гормонального компоненту менша кількості добових доз другого гормонального компоненту.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4321957A DE4321957C2 (de) | 1993-07-01 | 1993-07-01 | Verwendung eines hormonalen Mittels zur Therapie der Akne |
PCT/DE1994/000629 WO1995001180A1 (de) | 1993-07-01 | 1994-06-03 | Hormonales mittel zur therapie der akne und dessen verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
UA43337C2 true UA43337C2 (uk) | 2001-12-17 |
Family
ID=6491735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA95125308A UA43337C2 (uk) | 1993-07-01 | 1994-06-03 | Гормональний засіб для лікування вугрів |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0710111B1 (uk) |
JP (1) | JPH09500112A (uk) |
AT (1) | ATE205716T1 (uk) |
AU (1) | AU695894B2 (uk) |
BR (1) | BR9407340A (uk) |
CA (1) | CA2166121A1 (uk) |
DE (2) | DE4321957C2 (uk) |
DK (1) | DK0710111T3 (uk) |
ES (1) | ES2164103T3 (uk) |
HU (1) | HUT73234A (uk) |
NO (1) | NO308586B1 (uk) |
PT (1) | PT710111E (uk) |
UA (1) | UA43337C2 (uk) |
WO (1) | WO1995001180A1 (uk) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19534209A1 (de) * | 1995-09-15 | 1997-03-20 | Jenapharm Gmbh | Hormonales Mittel zur Behandlung der Haut |
WO1999033856A1 (fr) * | 1997-12-26 | 1999-07-08 | Mochida Pharmaceutical Co., Ltd. | Inhibiteur de neoformation de vaisseaux sanguins contenant du dienogest en tant que principe actif |
DE102004026671A1 (de) | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Darreichungsform zur hormonalen Kontrazeption |
DE102004026679A1 (de) * | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat |
DE102004026670A1 (de) * | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat |
DE102006003509A1 (de) * | 2006-01-24 | 2007-07-26 | Grünenthal GmbH | Kontrazeptivum |
DE102006003508A1 (de) * | 2006-01-24 | 2007-07-26 | Grünenthal GmbH | Arzneimittel umfassend eine Hormonkombination |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR79447B (uk) * | 1982-12-31 | 1984-10-30 | Mortimer Christopher H Dr | |
DE3442857A1 (de) * | 1984-11-22 | 1986-05-22 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mittel zur behandlung von androgenisierungserscheinungen bei der frau |
DE3916112A1 (de) * | 1989-05-16 | 1990-11-22 | Schering Ag | Dihydrospirorenon als antiandrogen |
DE4104385C1 (uk) * | 1991-02-09 | 1992-08-13 | Marika Dr.Med. 6509 Framersheim De Ehrlich |
-
1993
- 1993-07-01 DE DE4321957A patent/DE4321957C2/de not_active Expired - Lifetime
-
1994
- 1994-06-03 AT AT94916880T patent/ATE205716T1/de not_active IP Right Cessation
- 1994-06-03 PT PT94916880T patent/PT710111E/pt unknown
- 1994-06-03 ES ES94916880T patent/ES2164103T3/es not_active Expired - Lifetime
- 1994-06-03 WO PCT/DE1994/000629 patent/WO1995001180A1/de active IP Right Grant
- 1994-06-03 DK DK94916880T patent/DK0710111T3/da active
- 1994-06-03 EP EP94916880A patent/EP0710111B1/de not_active Expired - Lifetime
- 1994-06-03 HU HU9503770A patent/HUT73234A/hu unknown
- 1994-06-03 CA CA002166121A patent/CA2166121A1/en not_active Abandoned
- 1994-06-03 JP JP7503202A patent/JPH09500112A/ja active Pending
- 1994-06-03 DE DE59409869T patent/DE59409869D1/de not_active Expired - Fee Related
- 1994-06-03 AU AU68408/94A patent/AU695894B2/en not_active Ceased
- 1994-06-03 BR BR9407340A patent/BR9407340A/pt not_active Application Discontinuation
- 1994-06-03 UA UA95125308A patent/UA43337C2/uk unknown
-
1995
- 1995-12-29 NO NO955347A patent/NO308586B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO955347L (no) | 1995-12-29 |
ATE205716T1 (de) | 2001-10-15 |
CA2166121A1 (en) | 1995-01-12 |
AU6840894A (en) | 1995-01-24 |
NO955347D0 (no) | 1995-12-29 |
HU9503770D0 (en) | 1996-02-28 |
EP0710111B1 (de) | 2001-09-19 |
DE4321957A1 (de) | 1995-01-12 |
ES2164103T3 (es) | 2002-02-16 |
DE4321957C2 (de) | 1995-09-28 |
JPH09500112A (ja) | 1997-01-07 |
PT710111E (pt) | 2002-02-28 |
EP0710111A1 (de) | 1996-05-08 |
AU695894B2 (en) | 1998-08-27 |
BR9407340A (pt) | 1996-10-08 |
NO308586B1 (no) | 2000-10-02 |
DK0710111T3 (da) | 2001-12-10 |
HUT73234A (en) | 1996-07-29 |
DE59409869D1 (de) | 2001-10-25 |
WO1995001180A1 (de) | 1995-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY106272A (en) | Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants. | |
MY111556A (en) | Substituted azadioxacycloalkenes. | |
WO1994027589A3 (en) | Antidepressant dosage form | |
CZ540990A3 (en) | Microbicidal agent | |
GEP20032869B (en) | Alpha -Ketoamide Inhibitors of 20S Proteasome, Pharmaceutical Preparations Containing the Same and Methods for Treatment | |
PL315119A1 (en) | Agent for and method of performing hormonal contraception and/or treating acne | |
MY129973A (en) | Sulphonylbenzyl-substituted pyridones. | |
EP0489647A3 (en) | N,o-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them | |
MX9804395A (es) | Proceso y equipo anticonceptivos para mamiferos hembra, que comprenden una combinacion de gestageno y estrogeno. | |
GEP20012512B (en) | Inhibition of 26S and 20S Proteasome by Indanones | |
MY106528A (en) | Method of treating impotence. | |
ZA9333B (en) | Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone | |
MY106263A (en) | Method for the treatment or prevention of intrinsically aged skin with retinoids | |
AU584611B2 (en) | Kit for use in the treatment of osteoporosis | |
MX9602442A (es) | Un tratamiento con fluoroquinolona a dosis unica elevada. | |
MX9702035A (es) | Inhibidores de 5-alfa reductasa. | |
UA43337C2 (uk) | Гормональний засіб для лікування вугрів | |
KR100213963B1 (en) | Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis | |
GEP20032914B (en) | Derivatives of 1,3,4-Oxadiazolone | |
EP0366753A4 (en) | N-ALKOXYALKYLAMID AND COSMETIC TREATMENT COMPOSITIONS. | |
CA2179778A1 (en) | Deuterised active agents in transdermal application | |
MY115157A (en) | Method and composition for treatment of autoimmune hepatitis | |
AU1604592A (en) | New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments | |
TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
GR3036827T3 (en) | Method and composition for the treatment of hair loss. |